化合物 BVB-808 T71313
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
50 mg | 1180158-99-9 | ¥13,800.00 | 询底价 |
25 mg | 1180158-99-9 | ¥10,600.00 | 询底价 |
100 mg | 1180158-99-9 | ¥17,500.00 | 询底价 |
Product Introduction
Bioactivity
英文名: BVB-808
描述: BVB-808 is a selective Jak2 type 1 inhibitor. Janus kinases are critical components of signaling pathways that regulate hematopoiesis. Mutations of the non-receptor tyrosine kinase JAK2 are found in many BCR-ABL-negative myeloproliferative neoplasms. Preclinical results support that JAK2 inhibitors could show efficacy in treating chronic myeloproliferative neoplasms. JAK2 has also been postulated to play a role in BCR-ABL signal transduction. Therefore, inhibitors of JAK2 kinases are turning into therapeutic strategies for treatment of chronic myelogenous leukemia (CML).
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
化合物 BVB-808 T71313信息由TargetMol中国为您提供,如您想了解更多关于化合物 BVB-808 T71313报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途